Related Experiment Video
Updated: Jan 2, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Autoinhibition of the platelet-derived growth factor beta-receptor tyrosine kinase by its C-terminal tail
Federica Chiara1, Subal Bishayee, Carl-Henrik Heldin
1Ludwig Institute for Cancer Research, S-75124 Uppsala, Sweden.
Abstract:
In this report, we investigated the role of the C-terminal tail of the platelet-derived growth factor (PDGF) beta-receptor in the control of the receptor kinase activity. Using a panel of PDGF beta-receptor mutants with progressive C-terminal truncations, we observed that deletion of the last 46 residues, which contain a proline- and glutamic acid-rich motif, increased the autoactivation velocity in vitro and the V(max) of the phosphotransfer reaction, in the absence of ligand, as compared with wild-type receptors. By contrast, the kinase activity of mutant and wild-type receptors that were pre-activated by treatment with PDGF was comparable. Using a conformation-sensitive antibody, we found that truncated receptors presented an active conformation even in the absence of PDGF. A soluble peptide containing the Pro/Glu-rich motif specifically inhibited the PDGF beta-receptor kinase activity. Whereas deletion of this motif was not enough to confer ligand-independent transforming ability to the receptor, it dramatically enhanced the effect of the weakly activating D850N mutation in a focus formation assay. These findings indicate that allosteric inhibition of the PDGF beta-receptor by its C-terminal tail is one of the mechanisms involved in keeping the receptor inactive in the absence of ligand.
Insights
The platelet-derived growth factor (PDGF) beta-receptor
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- The platelet-derived growth factor (PDGF) beta-receptor is a key regulator of cell growth and survival.
- Its kinase activity is tightly controlled to prevent aberrant signaling.
- The C-terminal tail's role in regulating kinase activity remains incompletely understood.
Purpose of the Study:
- To investigate the role of the PDGF beta-receptor's C-terminal tail in controlling its kinase activity.
- To elucidate the mechanism by which the C-terminal tail regulates receptor autoactivation.
Main Methods:
- Site-directed mutagenesis to create PDGF beta-receptor mutants with progressive C-terminal truncations.
- In vitro kinase assays to measure autoactivation velocity and phosphotransfer kinetics.
- Conformation-sensitive antibody binding assays.
- Peptide inhibition assays.
- Focus formation assays to assess transforming ability.
Main Results:
- Deletion of the C-terminal 46 residues, including a Pro/Glu-rich motif, increased PDGF beta-receptor autoactivation in vitro.
- Truncated receptors adopted an active conformation even without PDGF binding.
- A peptide containing the Pro/Glu-rich motif inhibited PDGF beta-receptor kinase activity.
- Truncation enhanced the transforming potential of a weak activating mutation.
Conclusions:
- The C-terminal tail of the PDGF beta-receptor acts as an allosteric inhibitor, maintaining the receptor in an inactive state.
- This autoinhibitory mechanism is crucial for preventing ligand-independent receptor activation.
- The Pro/Glu-rich motif within the C-terminal tail plays a significant role in this inhibitory function.
Related Concept Videos
Receptor Tyrosine Kinases
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Amplifying Signals via Enzymatic Cascade
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

